Who has invested in TG Therapeutics?

Blue Owl Capital are named among the investors backing TG Therapeutics.

TG Therapeutics Funding: $250M Raised, Growth (2026)

TG Therapeutics funding overview

TG Therapeutics is based in New York. TG Therapeutics has raised $250M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in March 2026. The round record for TG Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Blue Owl Capital.

TG Therapeutics at a glance

Total raised: $250M
Latest round: Growth
Latest round date: March 2026
Headquarters: New York
Notable investors: Blue Owl Capital

Frequently asked about TG Therapeutics funding

How much has TG Therapeutics raised?: TG Therapeutics has raised $250M in total disclosed funding across the rounds on record.
Who has invested in TG Therapeutics?: Blue Owl Capital are named among the investors backing TG Therapeutics.
What was the latest TG Therapeutics funding round?: The most recent disclosed round is a Growth, announced in March 2026.
Where is TG Therapeutics based?: TG Therapeutics is based in New York.
When did TG Therapeutics last raise?: The last disclosed TG Therapeutics round closed in March 2026 at Growth.

Totals shown for TG Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in New York and the investors behind them below.

TG Therapeutics Funding: $250M Raised, Growth (2026)

TG Therapeutics funding overview

TG Therapeutics at a glance

Frequently asked about TG Therapeutics funding

Companies related to TG Therapeutics (25)

Browse related funding lists (6)